Strengthen Your Skills in Delivering Precision NSCLC Care to Your Patients – LUNGevity Foundation
LUNGevity Foundation shared a post on LinkedIn:
“Precision lung cancer care is advancing rapidly, driven by a deeper understanding of the disease biology, identification of additional actionable biomarkers, and validation and regulatory approval of a growing list of targeted therapies.
With this unprecedented progress comes new challenges related to testing and treatment in community and academic oncology practice.
View this PVI, PeerView Institute for Medical Education activity, recorded at ASCO 2025 and produced in partnership with the Oncology Brothers, for insights on actionable alterations in NSCLC, practical biomarker testing strategies, and evidence-based selection and sequencing of targeted therapies from early through advanced disease.
Watch now to strengthen your skills in delivering precision lung cancer care to your patients with NSCLC.”
More posts featuring LUNGevity Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023